Fervent Synergies Limited Share Price

Equities

FERVENTSYN6

INE258M01011

Fishing & Farming

Market Closed - Bombay S.E. 03:30:53 03/05/2024 pm IST 5-day change 1st Jan Change
17.34 INR +3.96% Intraday chart for Fervent Synergies Limited +4.84% -22.31%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
Sales 2022 6.98M 83.79K Sales 2023 46.3M 556K Capitalization 485M 5.82M
Net income 2022 -2M -24K Net income 2023 2M 24K EV / Sales 2022 63.2 x
Net cash position 2022 2.87M 34.41K Net cash position 2023 2.12M 25.46K EV / Sales 2023 10.4 x
P/E ratio 2022
-187 x
P/E ratio 2023
211 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 0%
More Fundamentals * Assessed data
Dynamic Chart
Fervent Synergies Limited Appoints Nehal Bharat Mehta as Company Secretary and Compliance Officer CI
Fervent Synergies Limited Announces Resignation of Pooja Sanghavi as Company Secretary / Compliance Officer CI
Fervent Synergies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Fervent Synergies Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Fervent Synergies Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Fervent Synergies Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
Fervent Synergies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Fervent Synergies Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Fervent Synergies Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Fervent Synergies Swings to Loss in Fiscal Q4 MT
Fervent Synergies Limited Reports Earnings Results for the Full Year Ended March 31, 2022 CI
Fervent Synergies Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022 CI
Fervent Pharmaceuticals Commences Virtual at Home Phase 2 Clinical Trial of a Peri- and Post-Menopausal Therapy for Treating Hot Flashes and Night Sweats CI
Fervent Synergies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Fervent Synergies Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
More news
1 day+3.96%
1 week+4.84%
Current month+5.73%
1 month-15.25%
3 months-25.16%
6 months-6.12%
Current year-22.31%
More quotes
1 week
16.15
Extreme 16.15
17.51
1 month
15.50
Extreme 15.5
20.46
Current year
15.50
Extreme 15.5
27.79
1 year
15.00
Extreme 15
27.79
3 years
11.10
Extreme 11.1
27.79
5 years
7.22
Extreme 7.22
28.45
10 years
7.22
Extreme 7.22
95.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 06/09/06
Director of Finance/CFO 35 23/15/23
Members of the board TitleAgeSince
Founder 60 06/09/06
Chief Executive Officer 58 06/09/06
Director/Board Member 63 01/11/01
More insiders
Date Price Change Volume
03/24/03 17.34 +3.96% 29,065
02/24/02 16.68 +1.71% 36,901
30/24/30 16.4 +0.61% 19,507
29/24/29 16.3 -1.45% 32,961

Delayed Quote Bombay S.E., May 03, 2024 at 03:30 pm IST

More quotes
Fervent Synergies Limited is an India-based company engaged in trading food items and financing/investment. The Company operates through two segments: Foods Business Division and Finance Business Division. Foods Business Division is engaged in trading almonds. Its Finance Business Division is engaged in business activities of erstwhile amalgamating companies i.e., funds lending, investing in fixed term deposits and similar securities.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. FERVENTSYN6 Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW